In the Winter 2019 issue of Viewpoints, Parkinson Society British Columbia (PSBC) shares tips for managing holiday stress for people with Parkinson’s disease (PD) and their carepartners. This issue also highlights the release of the updated Canadian Guidelines for...
As of November 26, 2019, apomorphine hydrochloride, sold under the brand name Movapo, has been made available as a part of BC PharmaCare’s Limited Drug Coverage Program under Special Authority. Special Authority grants coverage to a...
There have been several updates to the Limited Coverage Drug Program for the treatment of Parkinson's disease. Limited coverage drugs are not generally considered to be first-line therapies or there are more cost-effective alternatives. To be eligible for...
Back for its 7th year, the annual Chocolate and Beer Tasting at Moody Ales is sure to satisfy the most sophisticated tastebuds. Explore small batch chocolates from Take a Fancy Chocolates paired with a brew from Moody Ales with flavourful and...
As of October 17, 2018, the federal government, under Bill C-45, has legalized the purchase and consumption of marijuana (also referred to as cannabis) for Canadians. If you are considering the medical use of marijuana or its derivatives for Parkinson’s...
In the Fall 2019 issue of Viewpoints, Parkinson Society British Columbia (PSBC) highlights efforts to expand educational resources and increase access to healthcare professionals based on a recent community needs survey. This issue features an "Ask the Expert" section...
Parkinson Society British Columbia is proud to connect our community with the resources and tools they need to live well. Since Parkinson's disease (PD) can present differently in each individual, the Society endeavours to maintain impartiality when providing...
At the University of British Columbia, neuroscientist Jordan Follett is studying the retromer complex, which plays a key role in RNA sorting within cells. Follett’s research focuses on how mutations in this complex can disrupt the proper positioning of RNA, a crucial step for protein production, especially in dopamine-producing neurons.
The first edition of the Canadian Guidelines on Parkinson’s Disease was published in 2012. The second edition, providing updates with input from healthcare professionals, people with Parkinson's, and Parkinson Canada, was released in September 2019. The...
